Reinbold, R., Hvinden, I., Rabe, P., Herold, R., Finch, A., Wood, J., . . . Schofield, C. (2022). Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors. Springer Nature.
Citación estilo ChicagoReinbold, R., et al. Resistance to the Isocitrate Dehydrogenase 1 Mutant Inhibitor Ivosidenib Can Be Overcome by Alternative Dimer-interface Binding Inhibitors. Springer Nature, 2022.
Cita MLAReinbold, R., et al. Resistance to the Isocitrate Dehydrogenase 1 Mutant Inhibitor Ivosidenib Can Be Overcome by Alternative Dimer-interface Binding Inhibitors. Springer Nature, 2022.
Warning: These citations may not always be 100% accurate.